awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36086845-D4D1266E-8D0C-4707-BF12-82132A03FCF6
Q36086845-D4D1266E-8D0C-4707-BF12-82132A03FCF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36086845-D4D1266E-8D0C-4707-BF12-82132A03FCF6
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer.
P2860
Q36086845-D4D1266E-8D0C-4707-BF12-82132A03FCF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36086845-D4D1266E-8D0C-4707-BF12-82132A03FCF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c4b13bfa7cb44e799bb219e80a5e9c09ec667b3
P2860
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo